Peripheral neuropathies during biologic therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peripheral neuropathies during biologic therapies

Published:2013-12-09 Issue:2 Volume:26 Page:288-293
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Yagita Masato¹,Hamano Toshiaki²,Hatachi Saori¹,Fujita Masaaki³

Affiliation:

1. Department of Clinical Immunology and Rheumatology, The Tazuke-Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan

2. Department of Neurology, Kansai Electric Power Hospital, Osaka, Japan

3. Department of Dermatology, University of California Davis School of Medicine, Sacramento, CA, USA

Publisher

Informa UK Limited

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.3109/14397595.2013.859770

Reference49 articles.

1. New therapies for treatment of rheumatoid arthritis

2. Anti-tumour necrosis factor therapy in rheumatoid arthritis: an update on safety

3. Neurological Deficits During Treatment With Tumor Necrosis Factor-Alpha Antagonists

4. Neurological adverse events associated with anti-tumor necrosis factor alpha treatment

5. Monoclonal antibody therapy-associated neurological disorders

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic inflammatory demyelinating neuropathy after etanercept therapy in the course of juvenile idiopathic arthritis;The Turkish Journal of Pediatrics;2023

2. Ustekinumab in psoriasis: Five‐year real life experience from a single tertiary centre;Dermatologic Therapy;2020-01-14

3. Choosing the most appropriate biologic therapy for Crohn’s disease according to concomitant extra-intestinal manifestations, comorbidities, or physiologic conditions;Expert Opinion on Biological Therapy;2019-11-10

4. Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis;Archives of Pharmacy and Pharmaceutical Sciences;2017

5. Etanercept/infliximab;Reactions Weekly;2016-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3